CurveBeam AI Ltd CVB

Morningstar Rating
A$0.02 0.00 (15.00%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CVB is trading at a LOCK|%xR!J# premium.
Price
A$0.02
Fair Value
LOCK|f$b%zGy
Uncertainty
LOCK|dv XP^@
1-Star Price
LOCK|YYbd$<
5-Star Price
LOCK|S^^
Economic Moat
LOCK|NW
Capital Allocation
—

Trading Information

Previous Close Price
A$0.02
Day Range
A$0.02–0.03
52-Week Range
A$0.02–0.13
Bid/Ask
A$0.02 / A$0.02
Shares Outstanding
387.44M
Market Cap
A$19.94M
Volume/Avg
66M / 2M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
1.19
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the companies CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
—

Valuation

Metric
CVB
Price/Earnings (Normalized)
—
Price/Book Value
0.39
Price/Sales
1.19
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
CVB
Quick Ratio
0.52
Current Ratio
1.85
Interest Coverage
−21.72
Quick Ratio
CVB

Profitability

Metric
CVB
Return on Assets (Normalized)
−29.68%
Return on Equity (Normalized)
−52.52%
Return on Invested Capital (Normalized)
−32.91%
Return on Assets
CVB

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|!<Z@h>ZLOCK|tPG>$176B
Medtronic PLC
MDT
LOCK|^<R!DL<LOCK|M##c$118B
Stryker Corp
SYK
LOCK|$&<#k@mjLOCK|v&$108B
Boston Scientific Corp
BSX
LOCK|Yg$$hh$LOCK|R&pJ$64B
Edwards Lifesciences Corp
EW
LOCK|Dwb>L!x>LOCK|?ltJ^$50B
DexCom Inc
DXCM
LOCK|KC#?h%ZLOCK|JkPw$32B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|BX$%QxLOCK|@N$31B
Koninklijke Philips NV ADR
PHG
LOCK|^rwLOCK|^$x$24B
Steris PLC
STE
LOCK|Wm@&xyLOCK|!^@$n$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|GVwHpF$kLOCK|!B&$18B

Sponsor Center